You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利生物(603718.SH):新型冠狀病毒特異性抗體IgM-IgG檢測試劑盒(膠體金法)獲CE准入資質
格隆匯 06-08 15:59

格隆匯6月8日丨海利生物(603718.SH)公佈,公司全資子公司上海捷門生物技術有限公司(“捷門生物”)新型冠狀病毒(2019-nCOV)特異性抗IgM-IgG檢測試劑盒(膠體金法)2019nCOV IgM/IgG Antibody Test Kit (Colloidal Gold)】於近日取得了奧地利聯邦政府衞生、藥品醫療器械部門Bundesministerium für Soziales, Gesundheit, Pflege und Konsumentenschutz的備案憑證,具體情況如下

捷門生物此次獲得CE准入的產品抗體檢測試劑,具有檢測速度快、便於操作的特點,但抗體檢測僅用作對新型冠狀病毒核酸檢測陰性疑似病例的補充檢測指標或疑似病例診斷中與核酸檢測協同使用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account